文献速递心脏核医学肿瘤 PET/CT

68Ga-FAPI-04 PET显像探测心肌梗死后成纤维细胞活化

Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04.
PubMed 文献 · J Nucl Med · 2019-08-12

本研究在心肌梗死大鼠模型中评估68Ga-FAPI-04 PET/CT成像活化成纤维细胞的可行性,并与18F-FDG对比。结果显示示踪剂在梗死边缘区摄取最高、于梗死后第6天达峰,免疫荧光证实FAP阳性肌成纤维细胞存在。结论认为68Ga-FAPI-04是有前景的梗死后成纤维细胞活化在体显像探针。

要点

  • 68Ga-FAPI-04在梗死心肌摄取于冠脉结扎后第6天达峰。
  • 示踪剂主要蓄积于梗死边缘区,而非梗死中心。
  • 免疫荧光证实损伤心肌内存在FAP阳性肌成纤维细胞。

核心结论

  • 68Ga-FAPI-04是有前景的放射示踪剂,可用于心肌梗死后成纤维细胞活化的在体显像。
  • 对活化成纤维细胞的无创显像可能具有重要诊断和预后价值,有助于心梗后患者的临床管理。

研究设计与样本

  • 临床前研究,使用心肌梗死及假手术大鼠模型。
  • 心梗后1、3、6、14、23、30天行68Ga-FAPI-04 PET/CT,心梗后3天行18F-FDG显像。
  • 冠脉结扎后7天行68Ga-FAPI-04动态PET及阻断试验。
  • 显像后处死动物取心脏行离体分析,包括放射自显影、H&E及免疫荧光染色。

主要发现

  • 68Ga-FAPI-04在损伤心肌的摄取于冠脉结扎后第6天达峰。
  • 示踪剂在梗死区浓聚,该区域以18F-FDG摄取减低识别,并经PET/MR和H&E染色确认。
  • 放射自显影和H&E染色显示68Ga-FAPI-04主要蓄积于梗死心肌边缘区。
  • 阻断组大鼠梗死区摄取极少,与远隔非梗死心肌相当(PET图像推导的梗死/远隔摄取比值为6±2)。
  • 全心脏切片形态学分析显示边缘区FAP阳性成纤维细胞密度分别较梗死中心和远隔区高3倍和8倍。

临床怎么用

  • 68Ga-FAPI-04 PET可用于在体评估心梗后成纤维细胞活化的时空分布。
  • 成像可无创监测心肌修复与重构过程,有望辅助心梗后患者的风险分层与临床管理。

局限性

  • 研究为临床前大鼠模型,结论尚需临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heart failure remains a major source of late morbidity and mortality after myocardial infarction (MI). The temporospatial presence of activated fibroblasts in the injured myocardium predicts the quality of cardiac remodeling after MI. Therefore, monitoring of activated fibroblasts is of great interest for studying cardiac remodeling after MI. Fibroblast activation protein (FAP) expression is upregulated in activated fibroblasts. This study investigated the feasibility of imaging activated fibroblasts with a new 68Ga-labeled FAP inhibitor (68Ga-FAPI-04) for PET imaging of fibroblast activation in a preclinical model of MI. Methods: MI and sham-operated rats were scanned with 68Ga-FAPI-04 PET/CT (1, 3, 6, 14, 23, and 30 d after MI) and with 18F-FDG (3 d after MI). Dynamic 68Ga-FAPI-04 PET and blocking studies were performed on MI rats 7 d after coronary ligation. After in vivo scans, the animals were euthanized and their hearts harvested for ex vivo analyses. Cryosections were prepared for autoradiography, hematoxylin and eosin (H&E), and immunofluorescence staining. Results:68Ga-FAPI-04 uptake in the injured myocardium peaked on day 6 after coronary ligation. The tracer accumulated intensely in the MI territory, as identified by decreased 18F-FDG uptake and confirmed by PET/MR and H&E staining. Autoradiography and H&E staining of cross-sections revealed that 68Ga-FAPI-04 accumulated mainly at the border zone of the infarcted myocardium. In contrast, there was only minimal uptake in the infarct of the blocked rats, comparable to the uptake in the remote noninfarcted myocardium (PET image-derived ratio of infarct uptake to remote uptake: 6 ± 2). Immunofluorescence staining confirmed the presence of FAP-positive myofibroblasts in the injured myocardium. Morphometric analysis of the whole-heart sections demonstrated 3- and 8-fold higher FAP-positive fibroblast density in the border zone than in the infarct center and remote area, respectively. Conclusion:68Ga-FAPI-04 represents a promising radiotracer for in vivo imaging of post-MI fibroblast activation. Noninvasive imaging of activated fibroblasts may have significant diagnostic and prognostic value, which could aid clinical management of patients after MI.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Varasteh Z, Mohanta S, Robu S, et al. Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04. J Nucl Med. 2019. PMID: 31405922. doi:10.2967/jnumed.119.226993

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。